When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GWPH - Zogenix Gets Much-Needed FDA Reversal As It Looks To Tackle Major Competitor
GW Pharmaceuticals Plc
Zogenix (ZGNX) had a great day last week, because the FDA had agreed to allow it to resubmit its New Drug Application ((NDA)) for Fintepla for the treatment of seizures associated with Dravet syndrome. This is a major turn of events, especially since many months ago, the stock was crushed on the news that the FDA had given it a Refusal-to-File ((RTF)) letter. Now, the biotech can press forward for potential FDA approval and this was very exciting for investors. The stock closed higher by 21% the day this news was announced.